Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingping Zhang

Showing results (461-470 of 472) with videos related to

Pageof 48
Sort By:
The Lancet Regional Health. Western Pacific|August 22, 2024
Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6-14 years in China and its applications in high-obesity-risk countries and regionsYunfei Liu, Youxin Wang, Yunfei Xing, et al.
Allergy|August 4, 2022
Impact of air pollution and meteorological factors on incidence of allergic rhinitis: A low-latitude multi-city study in ChinaXin Luo, Haiyu Hong, Yongtian Lu, et al.
American Heart Journal|July 30, 2025
A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial designMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Nucleic Acids Research|December 31, 2025
Acoustically seeded fabrication of a DNA tesseract into a conductive wireSimon Chi-Chin Shiu, Marcello DeLuca, Wai Hin Chui, et al.
American Heart Journal|May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design UpdateMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Journal of the American College of Cardiology|August 30, 2025
Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV TrialKristoffer Grundtvig Skaarup, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Heart Journal|August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
The New England Journal of Medicine|September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older AdultsMats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
Diabetes Care|April 14, 2026
Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV TrialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology|June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV TrialCaroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
Pageof 48

Showing results (461-470 of 472) with videos related to

Sort By:
Pageof 48
The Lancet Regional Health. Western Pacific|August 22, 2024
Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6-14 years in China and its applications in high-obesity-risk countries and regionsYunfei Liu, Youxin Wang, Yunfei Xing, et al.
Allergy|August 4, 2022
Impact of air pollution and meteorological factors on incidence of allergic rhinitis: A low-latitude multi-city study in ChinaXin Luo, Haiyu Hong, Yongtian Lu, et al.
American Heart Journal|July 30, 2025
A pragmatic individually randomized trial to evaluate bivalent RSV prefusion F protein-based vaccine effectiveness for preventing RSV hospitalizations in adults aged 60 years or above (DAN-RSV): Rationale and trial designMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Nucleic Acids Research|December 31, 2025
Acoustically seeded fabrication of a DNA tesseract into a conductive wireSimon Chi-Chin Shiu, Marcello DeLuca, Wai Hin Chui, et al.
American Heart Journal|May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design UpdateMats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Journal of the American College of Cardiology|August 30, 2025
Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV TrialKristoffer Grundtvig Skaarup, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Heart Journal|August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
The New England Journal of Medicine|September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older AdultsMats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
Diabetes Care|April 14, 2026
Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV TrialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology|June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV TrialCaroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
Pageof 48